PUNE, India, February 1, 2016 /PRNewswire/ --
According to a new market research report "Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020", published by MarketsandMarkets, The market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020.
Browse 84 market Tables and 82 Figures spread through 158 Pages and in-depth TOC on "Epigenetics Market"
Early buyers will receive 10% customization on this report.
The global epigenetics market is poised to witness rapid growth between 2015 and 2020. High prevalence of cancer and increasing intensity of research activities will majorly drive the epigenetics market. Other growth drivers include the increasing funding, increasing application of non-oncology diseases and growing partnership between academic and biotechnology & pharmaceutical companies.
The market is segmented on the basis of product and research areas. By product, the market includes enzymes, instruments & consumables, kits and reagents. Enzymes are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further subsegmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. Kits are further subsegmented into bisulfite conversion kits, ChIP-seq kits, RNA sequencing kits, whole genomic sequencing kits, 5-hmc and 5-mc analysis kits and other epigenetics kits. Reagents are further subsegmented into antibodies, buffers, histones, magnetic beads, primers and other epigenetics reagents. Kits holds the largest share of the epigenetics market in 2015 and is also expected to lead the epigenetics product segment during the forecast period.
The research areas included in this report are developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases. Oncology segment will holds the largest share of the epigenetics market in 2015; however, drug discovery segment is expected to grow at a faster rate during the forecast period.
Ask for PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=896
The geographic segments included in this report are the North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada. North America is expected to hold the largest share of this market in 2015, while Asia is expected to grow at the fastest rate. Growth in the Asian epigenetics market will primarily be driven by the increasing R & D spending by biotechnology and pharmaceutical companies.
Major players in the global EPIGENETICS MARKET are Abcam plc. (U.K), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), Merck & Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.).
Browse Related Reports:
Nucleic Acid Isolation and Purification Market by Product (Reagents, Kits, Instruments), Technology (Column-, Reagent-, Magnetic Bead-based), Application (Plasmid, Genomic DNA, miRNA, Total RNA, PCR Clean-up), & End Users - Global Forecast to 2020
Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) - Global Forecast to 2018
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets